EkiYou

EkiYou is an AI-driven device designed to calculate the necessary insulin doses for diabetic patients. Developed by DiappyMed, the device was recently presented by DiappyMed's CEO, Coralie Lefevre, on the French Tech segment of the Good Morning Business program on March 23rd. The news articles highlight this presentation and the device's potential to improve insulin management for individuals with diabetes. The device's use of AI to determine insulin dosages is a significant development, suggesting a move towards more personalized and accurate diabetes care. Its relevance lies in the increasing need for effective diabetes management solutions, and EkiYou aims to address this need through innovative technology.